ProNAi Reports 2015 Year-End Financial and Operational Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
ProNAi Therapeutics (DNAI) Tops Q4 EPS by 20c
March 3, 2016 7:10 AM ESTProNAi Therapeutics (NASDAQ: DNAI) reported Q4 EPS of ($0.38), $0.20 better than the analyst estimate of ($0.58).
For earnings history and earnings-related data on ProNAi Therapeutics (DNAI) click here.
... More


